Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
18,289,035
-
Share change
-
+69,023
-
Total reported value
-
$2,261,057,087
-
Put/Call ratio
-
55%
-
Price per share
-
$123.61
-
Number of holders
-
196
-
Value change
-
+$8,645,237
-
Number of buys
-
3
-
Number of sells
-
5
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2013
As of 31 Dec 2013 BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) had 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,289,035 shares of stock of the company.
Largest 10 holders included ATLANTA CAPITAL MANAGEMENT CO L L C, ARIEL INVESTMENTS, LLC, VANGUARD GROUP INC, ROYCE & ASSOCIATES LLC, LEVIN CAPITAL STRATEGIES, L.P., Champlain Investment Partners, LLC, BlackRock Institutional Trust Company, N.A., UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Fund Advisors, and State Street Corp.
This table shows 196 institutional shareholders of the security as of 31 Dec 2013.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.